z-logo
open-access-imgOpen Access
Oncogenic function of p34SEI-1 via NEDD4-1-mediated PTEN ubiquitination/degradation and activation of the PI3K/AKT pathway
Author(s) -
Samil Jung,
Chengping Li,
Dongjun Jeong,
Soonduck Lee,
Jiyeon Ohk,
Meeyoung Park,
Shuang Han,
Jingjing Duan,
Changjin Kim,
Young Yang,
Keun-Il Kim,
JongSeok Lim,
YoungSook Kang,
MyeongSok Lee
Publication year - 2013
Publication title -
international journal of oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.405
H-Index - 122
ISSN - 1019-6439
DOI - 10.3892/ijo.2013.2064
Subject(s) - pten , ubiquitin , biology , nedd4 , pi3k/akt/mtor pathway , oncogene , protein kinase b , cancer research , function (biology) , microbiology and biotechnology , cell cycle , cancer , ubiquitin ligase , signal transduction , genetics , gene
A 34-KD protein encoded by the SEI-1 gene (p34(SEI‑1)), is a relatively recently discovered oncoprotein that has multiple important biological functions. Our data show that p34(SEI-1) enhances cancer cell survival and promotes tumorigenesis by downregulating the tumor suppressor PTEN, a negative regulator of the PI3K/AKT signaling pathway, and therefore activating the PI3K/AKT signaling pathway. In this process, p34(SEI-1) positively affects NEDD4-1 gene expression both at the transcriptional and protein levels. Furthermore, the expression levels of p34(SEI-1) and NEDD4-1 were found to be coordinated in tumor tissues obtained from patients with breast cancer. We also show that p34(SEI-1) affects the subcellular localization of PTEN.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here